Lorus Therapeutics Creates Strategic Alliance With Faulding Canada Inc. For Lead Cancer Compound Virulizin.
Business Wire (April 01, 1999)
Permanent Link:
http://vlex.com/vid/lorus-therapeutics-faulding-compound-virulizin-53929713
Id. vLex: VLEX-53929713
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Lorus Therapeutics Creates Strategic Alliance With Faulding Canada Inc. For Lead Cancer Compound Virulizin.
TORONTO--(BUSINESS WIRE)--April 1, 1999--Lorus Therapeutics I (NASDAQ:LORFF) (TSE:LOR) (ME:LOR)
Lorus and Faulding to co-develop Virulizin(r) in Canada for pancreatic cancer Lorus Therapeutics Inc. today announ...Try vLex for FREE for 3 days
Access legal information from United States including:
- Constitutions
- Forms and Contracts
- Legal Books and Journals
- Case Law
- News and Business
- Regulations
- U.S. Code
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
Other documents:
Murillo el Cuende -
Aprobacion inicial de expediente de habilitacion de creditos
extraor... |
Bombardier John Harris and the Rivers of the Revolution. |
editorial: postanarchism. |
Decisão Monocrática Nº 70030351134 of Tribunal de Justiça do RS - Terceira Câmara Cível, of June 15, 2009
|
METALES (Londres) |
Sentenza n 1804 of T.A.R. - Campania - Napoli, of February 26, 2003
|
Arrêt of IIe Cour de Droit Civil of Tribunal Federal Nº 83 II 510, of October 31, 1957
|
Saneamento e Energia
|
Arrete du 30 octobre 1998 relatif a la prime de sujetions particulieres allouee aux personnels admini... |
Meetings
National Institute of Allergy and Infectious Diseases,
